The correlation between metabolic syndrome and calcium urolithiasis

Authors

  • Adil Abdulla Department of Urology and Renal Transplant, Government Medical College Kozhikode, Kerala, India https://orcid.org/0000-0001-6209-299X
  • Shanmugha Das Department of Urology and Renal Transplant, Government Medical College Kozhikode, Kerala, India
  • Venugopalan A. V. Department of Urology and Renal Transplant, Government Medical College Kozhikode, Kerala, India
  • Rajeevan A. T. Department of Urology and Renal Transplant, Government Medical College Kozhikode, Kerala, India
  • Manikandan M. Department of Urology and Renal Transplant, Government Medical College Kozhikode, Kerala, India

DOI:

https://doi.org/10.18203/2349-2902.isj20232639

Keywords:

Urolithiasis, Metabolic syndrome, Calcium stones

Abstract

Background: Urolithiasis affects about 12% of the global population. This study helps us to find the correlation between metabolic syndrome, its components and the risk of calcium stone urolithiasis.

Methods: A cross-sectional study was conducted on 140 patients who underwent surgery for urolithiasis and whose stones were calcium-containing. A group of subjects who never had a history of urolithiasis was taken as control. Various anthropometric and biochemical parameters were studied to estimate and compare the prevalence of metabolic syndrome in both the groups.

Results: The study showed that the central obesity of the study population was higher. However, even though prevalence of hypertension was more in the stone group compared to the control population, this difference was not statistically significant. On analysis of biochemical parameters like fasting blood sugar, triglycerides and HDL, abnormal triglycerides and HDL were significantly higher in the stone group when compared to the control. On consideration of all parameters as per international diabetes federation (IDF) definition, prevalence of metabolic syndrome in stone group was 40% which was higher than the control group with 25% and the difference was statistically significant. While summing up the number of parameters of metabolic syndrome an individual has in each group it is evident that the proportion of patients in the stone group had a greater number of parameters compared to the control group.

Conclusions: This study could conclude that there is a significant correlation between calcium urolithiasis and metabolic syndrome.

 

References

Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. The lancet. 2005;365(9468):1415-28.

Buchholz NPN, Abbas F, Afzal M, Khan R, Rizvi I, Talati J. The prevalence of silent kidney stones--an ultrasonographic screening study. JPMA J Pak Med Assoc. 2003;53(1):24-5.

Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016;388(10053):1459-544.

Antonelli JA, Maalouf NM, Pearle MS, Lotan Y. Use of the National Health and Nutrition Examination Survey to Calculate the Impact of Obesity and Diabetes on Cost and Prevalence of Urolithiasis in 2030. Eur Urol. 2014;66(4):724-9.

Madore F. Nephrolithiasis and Risk of Hypertension. Am J Hypertens. 1998;11(1):46-53.

Taylor EN, Stampfer MJ, Curhan GC. Diabetes mellitus and the risk of nephrolithiasis. Kidney Int. 2005;68(3):1230-5.

Taylor EN. Obesity, Weight Gain, and the Risk of Kidney Stones. JAMA. 2005;293(4):455.

Sakhaee K, Maalouf NM. Metabolic syndrome and uric acid nephrolithiasis. Semin Nephrol. 2008;28(2):174-80.

Sakhaee K. Recent advances in the pathophysiology of nephrolithiasis. Kidney Int. 2009;75(6):585-95.

Pak CYC, Sakhaee K, Peterson RD, Poindexter JR, Frawley WH. Biochemical profile of idiopathic uric acid nephrolithiasis. Kidney Int. 2001;60(2):757-61.

Sarica K, Altay B, Erturhan S. Effect of being overweight on stone-forming risk factors. Urology. 2008;71(5):771-5.

Daudon M, Traxer O, Conort P, Lacour B, Jungers P. Type 2 diabetes increases the risk for uric acid stones. J Am Soc Nephrol JASN. 2006;17(7):2026-33.

Eisner BH, Porten SP, Bechis SK, Stoller ML. Hypertension is associated with increased urinary calcium excretion in patients with nephrolithiasis. J Urol. 2010;183(2):576-9.

Meydan N, Barutca S, Caliskan S, Camsari T. Urinary stone disease in diabetes mellitus. Scand J Urol Nephrol. 2003;37(1):64-70.

Lieske JC, Swift H, Martin T, Patterson B, Toback FG. Renal epithelial cells rapidly bind and internalize calcium oxalate monohydrate crystals. Proc Natl Acad Sci. 1994;91(15):6987-91.

West B, Luke A, Durazo-Arvizu RA, Cao G, Shoham D, Kramer H. Metabolic syndrome and self-reported history of kidney stones: the National Health and Nutrition Examination Survey (NHANES III) 1988-1994. Am J Kidney Dis Off J Natl Kidney Found. 2008;51(5):741-7.

Downloads

Published

2023-08-28

Issue

Section

Original Research Articles